Cargando…

Modeling of Chronic Myeloid Leukemia: An Overview of In Vivo Murine and Human Xenograft Models

Over the past years, a wide variety of in vivo mouse models have been generated in order to unravel the molecular pathology of Chronic Myeloid Leukemia (CML) and to develop and improve therapeutic approaches. These models range from (conditional) transgenic models, knock-in models, and murine bone m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sontakke, Pallavi, Jaques, Jenny, Vellenga, Edo, Schuringa, Jan Jacob
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5014953/ https://www.ncbi.nlm.nih.gov/pubmed/27642303 http://dx.doi.org/10.1155/2016/1625015

Ejemplares similares

Dasatinib impairs long-term expansion of leukemic progenitors in a subset of acute myeloid leukemia cases
por: Han, Lina, et al.
Publicado: (2010)

Inhibition of autophagy as a treatment strategy for p53 wild-type acute myeloid leukemia
por: Folkerts, Hendrik, et al.
Publicado: (2017)

Elevated VMP1 expression in acute myeloid leukemia amplifies autophagy and is protective against venetoclax-induced apoptosis
por: Folkerts, Hendrik, et al.
Publicado: (2019)

Hypoxia-Like Signatures Induced by BCR-ABL Potentially Alter the Glutamine Uptake for Maintaining Oxidative Phosphorylation
por: Sontakke, Pallavi, et al.
Publicado: (2016)

The IL1-IL1RAP axis plays an important role in the inflammatory leukemic niche that favors acute myeloid leukemia proliferation over normal hematopoiesis
por: de Boer, Bauke, et al.
Publicado: (2020)

Convergence of Hypoxia and TGFβ Pathways on Cell Cycle Regulation in Human Hematopoietic Stem/Progenitor Cells
por: Wierenga, Albertus T. J., et al.
Publicado: (2014)

ELMO1 Is Upregulated in AML CD34+ Stem/Progenitor Cells, Mediates Chemotaxis and Predicts Poor Prognosis in Normal Karyotype AML
por: Capala, Marta E., et al.
Publicado: (2014)

Murine models based on acute myeloid leukemia-initiating stem cells xenografting
por: Mambet, Cristina, et al.
Publicado: (2018)

STAT5-mediated self-renewal of normal hematopoietic and leukemic stem cells
por: Schepers, Hein, et al.
Publicado: (2012)

Murine Models of Acute Myeloid Leukemia
por: Kurtz, Kristen J., et al.
Publicado: (2022)

Modeling cell proliferation in human acute myeloid leukemia xenografts
por: Nobile, Marco S, et al.
Publicado: (2019)

Single-Cell STAT5 Signal Transduction Profiling in Normal and Leukemic Stem and Progenitor Cell Populations Reveals Highly Distinct Cytokine Responses
por: Han, Lina, et al.
Publicado: (2009)

Imatinib in Chronic Myeloid Leukemia: an Overview
por: Sacha, Tomasz
Publicado: (2014)

Therapeutic activity of two xanthones in a xenograft murine model of human chronic lymphocytic leukemia
por: Loisel, Séverine, et al.
Publicado: (2010)

Radiation-induced myeloid leukemia in murine models
por: Rivina, Leena, et al.
Publicado: (2014)

Corrigendum: Murine models of acute myeloid leukemia
por: Kurtz, Kristen J., et al.
Publicado: (2023)

Overview of the Use of Murine Models in Leukemia and Lymphoma Research
por: Kohnken, Rebecca, et al.
Publicado: (2017)

BRD3/4 inhibition and FLT3-ligand deprivation target pathways that are essential for the survival of human MLL-AF9(+) leukemic cells
por: Carretta, Marco, et al.
Publicado: (2017)

Efficacy of Flotetuzumab in Combination with Cytarabine in Patient-Derived Xenograft Models of Pediatric Acute Myeloid Leukemia
por: Barwe, Sonali P., et al.
Publicado: (2022)

Mitochondrial Dysfunction in Human Leukemic Stem/Progenitor Cells upon Loss of RAC2
por: Capala, Marta E., et al.
Publicado: (2015)

Short overview on the current treatment of chronic myeloid leukemia in chronic phase
por: Schmidt, Stefan
Publicado: (2016)

An improved pre-clinical patient-derived liquid xenograft mouse model for acute myeloid leukemia
por: Her, Zhisheng, et al.
Publicado: (2017)

An Overview and Update of Chronic Myeloid Leukemia for Primary Care Physicians
por: Granatowicz, Austin, et al.
Publicado: (2015)

Transcription factor 4 (TCF4) expression predicts clinical outcome in RUNX1 mutated and translocated acute myeloid leukemia
por: in 't Hout, Florentien E. M., et al.
Publicado: (2020)

A robust and rapid xenograft model to assess efficacy of chemotherapeutic agents for human acute myeloid leukemia
por: Saland, E, et al.
Publicado: (2015)

Acute myeloid leukemia xenograft success prediction: Saving time
por: Griessinger, Emmanuel, et al.
Publicado: (2018)

The CRISPR/Cas9 system efficiently reverts the tumorigenic ability of BCR/ABL in vitro and in a xenograft model of chronic myeloid leukemia
por: García-Tuñón, Ignacio, et al.
Publicado: (2017)

Effective drug treatment identified by in vivo screening in a transplantable patient-derived xenograft model of chronic myelomonocytic leukemia
por: Kloos, Arnold, et al.
Publicado: (2020)

Residual Disease in a Novel Xenograft Model of RUNX1-Mutated, Cytogenetically Normal Acute Myeloid Leukemia
por: Sivagnanalingam, Umayal, et al.
Publicado: (2015)

An aging mouse model of human chronic myeloid leukemia
por: Hao, Taisen, et al.
Publicado: (2021)

Artesunate suppresses tumor growth and induces apoptosis through the modulation of multiple oncogenic cascades in a chronic myeloid leukemia xenograft mouse model
por: Kim, Chulwon, et al.
Publicado: (2015)

Correction: Effective drug treatment identified by in vivo screening in a transplantable patient-derived xenograft model of chronic myelomonocytic leukemia
por: Kloos, Arnold, et al.
Publicado: (2021)

An Overview of Targeted Therapies in Acute Myeloid Leukemia
por: Turkalj, Sven, et al.
Publicado: (2023)

In Vivo Murine Model of Leukemia Cell-Induced Spinal Bone Destruction
por: Chen, Jia-Jie, et al.
Publicado: (2017)

Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24-month follow-up
por: Gambacorti-Passerini, Carlo, et al.
Publicado: (2014)

Bortezomib has little ex vivo activity in chronic myeloid leukemia: individual tumor response testing comparative study in acute and chronic myeloid leukemia
por: Styczyński, Jan, et al.
Publicado: (2012)

Sequential Treatment with Cytarabine and Decitabine Has an Increased Anti-Leukemia Effect Compared to Cytarabine Alone in Xenograft Models of Childhood Acute Myeloid Leukemia
por: Leonard, Sarah M., et al.
Publicado: (2014)

P414: PATIENT-DERIVED XENOGRAFT MODELS ARE THE LEADING STRATEGY TO IDENTIFY NEW AGENTS FOR PEDIATRIC ACUTE MYELOID LEUKEMIA
por: Da Ros, Ambra, et al.
Publicado: (2023)

High Acute Myeloid Leukemia derived VEGFA levels are associated with a specific vascular morphology in the leukemic bone marrow
por: Weidenaar, Alida C., et al.
Publicado: (2011)

In vivo genome-wide CRISPR screening in murine acute myeloid leukemia uncovers microenvironmental dependencies
por: Mercier, Francois E., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3ahs2nvj6083lrleeueu52qp1i